Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia

Molecular Endocrinology

Volumn 12, Issue 11, 1998, Pages 1651-1660

  Wu, Shao Ming ^a   Hallermeier, Karen M ^b   Laue, Louisa ^a   Brain, Caroline ^c,h   Berry, A Caroline ^d   Grant, David B ^c   Griffin, James E ^e   Wilson, Jean D ^e   Cutler Jr , Gordon B ^f,i   Chan, Wai Yee ^a,b,g  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^g GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^h ST GEORGE S HOSPITAL   (United Kingdom)

ⁱ ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE;

ALLELE; ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; DRUG RECEPTOR BINDING; FIBROBLAST; GENE AMPLIFICATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HYPOPLASIA; LEYDIG CELL; LUTEINIZING HORMONE RELEASE; NONSENSE MUTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

EID: 14444287261     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.12.11.0189     Document Type: Article

References (42)

1. Dufau ML 1996 The luteinizing hormone receptor. In: Payne AH, Hardy MP, Russell LD (eds) The Leydig Cell. Cache River Press, Vienna, IL, pp 333-350
2. Schwartz M, Imperato-McGinley J, Peterson RE, Cooper G, Morris PL, MacGillivray M, Hensle T 1981 Male pseudohermaphroditism secondary to an abnormality in Leydig cell differentiation. J Clin Endocrinol Metab 53:123-127
3. El-Awady MK, Temtamy SA, Salam MA, Gad YZ 1987 Familial Leydig cell hypoplasia as a cause of male pseudohermaphroditism. Hum Hered 37:36-40
4. Toledo SPA 1992 Leydig cell hypoplasia leading to two different phenotypes: male pseudohermaphroditism and primary hypogonadism not associated with this. Clin Endocrinol (Oxf) 36:521-522
5. Kremer H, Kraaij R, Toledo SPA, Post M, Fridman JB, Hayashida CY, van Reen M, Milgrom E, Ropers HH, Mariman E, Themmen APN, Brunner HG 1995 Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 9:160-164
6. Laue L, Wu SM, Kudo M, Hsueh AJW, Cutler GB, Griffin JE, Wilson JD, Brain C, Berry AC, Grant DB, Chan WY 1995 A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet 4:1429-1433
7. Latronico AC, Anasti J, Arnhold IJP, Rapaport R, Mendonca BB, Bloise W, Castro M, Tsigos C, Chrousos GP 1996 Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 334:507-512
8. Laue LL, Wu SM, Kudo M, Bourdony CJ, Cutler Jr GB, Hsueh AJW, Chan WY 1996 Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol Endocrinol 10:987-997
9. Toledo SPA, Brunner HG, Kraaij R, Post M, Dahia PLM, Hayashida CY, Kremer H, Themmen APN 1996 An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J Clin Endocrinol Metab 81:3850-3864
10. Stavrou SS, Zhu YS, Cai LQ, Katz MD, Herrera C, DeFillo-Ricart M, Imperato-McGinley J, A novel mutation of LH receptor presents as primary amenorrhea in (XX and XY) sisters. Program of the 79th Annual Meeting of The Endocrine Society, Minneapolis, MN, 1997, p 120 (Abstract)
11. Misrahi M, Meduri G, Pissard S, Bouvattier C, Beau I, Loosfelt H, Jolivet A, Rappaport R, Milgrom E, Bougneres P 1997 Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J Clin Endocrinol Metab 62:2159-2165
12. Martens JWM, Verhoef-Post M, Abelin N, Ezabella M, Toledo SPA, Brunner HG, Themmen APN 1998 A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. Mol Endocrinol 12:775-784
13. Latronico AC, Chai Y, Arnhold IJP, Liu X, Mendonca BB, Segaloff DL 1998 A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol 12:442-450
14. Wu SM, Jose M, Hallermeier K, Rennert OM, Chan WY 1997 Polymorphisms in the coding exons of the human luteinizing hormone receptor gene. Hum Mutat 11:333-334 [Mutation in Brief #124, on line]
15. Minegishi T, Nakamura K, Takakura Y, Miyamoto K, Hasegawa Y, Ibuki Y, Igarashi M 1990 Cloning and sequencing of human LH/hCG receptor cDNA. Biochem Biophys Res Commun 172:1049-1054
16. Yu S, Pritchard M, Kremer E, Lynch M, Nancarrow J, Baker E, Holman K, Mulley JC, Warren ST, Schlessinger D, Sutherland GR, Richards RI 1991 Fragile X genotype characterized by an unstable region of DNA. Science 252:1179-1181
17. Innis MA 1990 PCR with 7-deaza-2′-deoxyguanosine triphosphate. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds) PCR Protocols. Academic Press, San Diego, CA, pp 54-59
18. Bartolomei MS, Tilghman SM 1997 Genomic imprinting in mammals. Annu Rev Genet 31:493-525
19. Moyle WR, Campbell RK, Rao SNV, Ayad NG, Bernard MP, Han Y, Wang Y 1995 Model of human chorionic gonadotropin and lutropin receptor interaction that explains signal transduction of the glycoprotein hormones. J Biol Chem 270:20020-20031
20. Tayare NE 1996 Advances in the molecular understanding of gonadotropins-receptors interactions. Mol Cell Endocrinol 125:65-70
21. Bhowmick N, Huang J, Puett D, Isaacs NW, Lapthorn AJ 1996 Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling. Mol Endocrinol 10:1147-1159
22. McFarland KC, Sprengel R, Phillips HS, Köhler M, Rosemblit N, Nikolics K, Segaloff DL, Seeburg PH 1989 Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science 245:494-499
23. Steinlein OK, Magnusson A, Stoodt J, Bertrand S, Weiland S, Berkovic SF, Nakken KO, Propping P, Bertrand D 1997 An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet 6:943-947
24. Braun T, Schofield PR, Sprengel R 1991 Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity. EMBO J 10:1885-1890
25. Gusella JF, MacDonald ME 1996 Trinucleotide instability: a repeating theme in human inherited disorders. Annu Rev Med 47:201-209
26. Richards RI, Sutherland GR 1997 Dynamic mutation: possible mechanisms and significance in human disease. Trends Biochem Sci 22:432-436
27. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL 1991 Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822
28. Maxson R, Cohn R, Kedes L, Mohun T 1983 Expression and organization of histone genes. Annu Rev Genet 17:239-277
29. H segmental elements during vertebrate evolution. Nature 320:546-549
30. Higgs DR, Vickers MA, Wilkie AOM, Pretorius IM, Jarman AP, Weatherall DJ 1989 A review of the molecular genetics of the human α-globulin gene cluster. Blood 73:1081-1104
31. Chan WY 1991 The pregnancy-specific β1-glycoprotein family. Adv Contracept Deliv Syst 7:21-52
32. Creighton TE 1984 Evolutionary and genetic origins of protein sequences. In: Creighton TE (ed) Proteins: Structure and Molecular Principles. Freeman, New York, NY, pp 93-126
33. Hu X, Worton RG 1992 Partial gene duplication as a cause of human disease. Hum Mutat 1:3-12
34. Tiller GE, Rimoin DL, Murray LW, Cohn DH 1990 Tandem duplication within a type II collagen gene (COL2A1) exon in an individual with spondyloepiphyseal dysplasia. Proc Natl Acad Sci USA 87:3889-3893
35. Jeikkinen J, Toppinen T, Yeowell H, Krieg T, Steinmann B, Kivirikko KI, Myllyla R 1997 Duplication of seven exons in the lysyl hydroxylase gene is associated with longer forms of a repetitive sequence within the gene and is a common cause for the type VI variant of Ehlers-Danlos syndrome. Am J Hum Genet 60:48-56
36. Atger M, Misrahi M, Sar S, Fle LL, Dessen P, Milgrom E 1995 Structure of the human luteinizing hormone-choriogonadotropin receptor gene: unusual promoter and 5′ non-coding regions. Mol Cell Endocrinol 111:113-123
37. Wu SM, Blomberg LA, Chan WY 1996 Recovery of unlabeled PCR product from polyacrylamide gel for sequencing. Biotechniques 21:358-362
38. Chomczynski P, Sacchi N 1986 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
39. Wu SM, Bazar LS, Cohn ML, Cahill RA, Chan WY 1993 Expression of pregnancy-specific β1-glycoproteins in hematopoietic cells. Mol Cell Biochem 122:147-152
40. Hawley-Nelson P, Ciccarone V, Gebeyehu G, Jessee J, Felgner PL 1993 Lipofectamine™ reagent: a new, higher efficiency polycationic liposome transfection reagent. Focus 15:73-79
41. Lloyd CE, Ascoli M 1983 On the mechanisms involved in the regulation of the cell-surface receptors for human choriogonadotropin and mouse epidermal growth factor in cultured Leydig tumor cells. J Cell Biol 96:521-526
42. Ascoli M 1983 An improved method for the solubilization of stable gonadotropin receptors. Endocrinology 113:2129-2134